12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

NiCord: Phase I/II started

Gamida Cell began an open-label, U.S. Phase I/II trial to evaluate co-transplantation of NiCord and a second, unmanipulated cord blood unit in about 10...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >